QUINOLONE ANALOGUES Russian patent published in 2009 - IPC C07D215/58 C07D401/04 C07D471/14 C07D513/14 A61K31/4745 A61P31/00 A61P35/00 

Abstract RU 2349586 C2

FIELD: chemistry.

SUBSTANCE: present invention pertains to new compounds with formula (1): and to their pharmaceutical salts, where B, X, A or V are not present, if Z1, Z2, Z3 or Z4 respectively represent N, and independently H, halogen atom, azido, R2, CH2R2, SR2, OR2 or NR1R2, when Z1, Z2, Z3 or Z4 represent C. In each NR1R2, R1 and R2 together with N there can be formation of an optionally substituted piperidine, pyrrolidine, piperazine or morpholine ring. Z1 represents N and Z2, Z3 and Z4 represent C, or Z1 and Z3 represent N and Z2 and Z4 represent C. W together with N and Z form an optionally substituted thiazole, imidazole or pyrimidine ring, which is condensed with an optionally substituted ring, chosen from a group consisting of: or . U represents NR1R2, NR1-(CR12)n-NR3R4, where in NR3R4, R3 and R4 together with N there can be formation of an optionally substituted piperidine, pyrrolidine, piperazine or morpholine ring. R1 and R3 independently represent H or C1-6alkyl. Each R2 represents H or C1-10alkyl, each optionally substituted with a halogen atom, or C3-6cycloalkyl, aryl, heteroaryl or pyridine, pyrrolidine, piperazine or morpholine ring, where each ring is optionally substituted; or R2 is optionally substituted with piperidine, pyrrolidine, pyridine, piperazine, pyrazine, morpholine or benzimidazole. R2 represents H or C1-10alkyl. Each R5 represents a substitute in any position in ring W, and is H, OR2, amino, alkoxy, amido, halogen atom or cyano; or R5 represents C1-6alkyl, -CONHR1-, each optionally substituted with a halogen atom; or two adjacent R5 are linked with formation of a 5-6-member ring, an optionally substituted heterocyclic ring, chosen piperidine, pyrrolidine, piperazine or morpholine ring. n equals 1-6, and each optionally substituted part can be substituted with one or more halogens, OR2, NR1R2 , carbamate, C1-10alkyl, each optionally substituted with a halogen atom, C=O, cyano, nitro, COR2, NR2COR2, sulphonyl amides, NR2SOOR2; SR2, SOR2, COOR2, CONR22, OCOR2, OCOOR2 or OCONR22. The invention also relates to pharmaceutical compositions, to the method of suppressing proliferation of cells and/or weakening cell proliferative breakdown, to the method of reducing microbe titre and/or weakening microbe infection, to the method of inducing death of cells and/or inducing apoptosis, to compounds, chosen from a group, to pharmaceutical compositions, as well as to the method of producing compounds with formula (1).

EFFECT: obtaining new biologically active compounds, which can suppress proliferation of cells and/or induce apoptosis.

41 cl, 113 ex, 12 tbl

Similar patents RU2349586C2

Title Year Author Number
QUINOLONE ANALOGUES AND RELATED METHODS 2008
  • Nagasava Dzhonni Jasuo
  • P'Er Fabris
  • Khaddakh Mustafa
  • Shvebe Majkl
  • Dardzhanija Levan
  • Vitten Dzheffri P.
RU2549895C2
SERINE-THREONINE PROTEIN KINASE AND PARP MODULATORS 2013
  • Chua Piter K.
  • Per Fabris
  • Vitten Dzheffri P.
RU2681209C2
CASPASE INHIBITORS 1999
  • Vannamehjker Marion V.
  • Bemis Gaj V.
  • Charifson Pol S.
  • Loffer Dehvid Dzh.
  • Mallikan Majkl D.
  • Merko Mark A.
  • Vilson Kejt P.
  • Dzhanetka Dzhehjms V.
  • Dehvis Robert Dzh.
  • Grilo Ann-Lor
  • Shi Zan
  • Forster Kornelia Dzh.
RU2274642C2
INTERLEIKYN-1BETA CONVERTING ENZYME INHIBITORS 1996
  • Mark Dzh. Behtchelor
  • Dehvid Bebbington
  • Gaj V. Bemiz
  • Vol'F German Fridman
  • Rodzher Dzh. Dzhillspaj
  • Dzhulian M. S. Golek
  • Jong Gu
  • Dehvid Dzh. Lauffer
  • Dehvid Dzh. Livingston
  • Saroop S. Matkharu
  • Majkl D. Mallikan
  • Mark A. Merko
  • Robert Merdokh
  • Filip L. Najs
  • Andrea L. S. Robidu
  • Majkl Su
  • M. Vudz Vannamehjker
  • Kejt P. Uilson
  • Robert E. Zelle
RU2249598C2
6,6-BICYCLIC RING SUBSTITUTED HETEROBICYCLIC PROTEINKINASE INHIBITORS 2005
  • Arnol'D Li D.
  • Sesario Kara
  • Kout Khiter
  • Krju Ehndrju Filip
  • Dun Khan'Tsin
  • Forman Kennet
  • Khonda Ajako
  • Laufer Radoslav
  • Li An'-Khu
  • Malvikhill Kristen Mishel'
  • Malvikhill Mark Dzhozef
  • Najgro Ehntoni
  • Paniker Bidzhoj
  • Shtajnig Arno G.
  • Sun' Inchuan'
  • Vehn Tsinkhua
  • Verner Duglas S.
  • Uajl Majkl Dzh.
  • Chzhan Tao
RU2379308C2
HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR USE 2012
  • Khadd Majkl Dzh.
  • Khoker Majkl D.
  • Kholladej Mark U.
  • Lyu Gan
  • Roubottom Martin U.
  • Syuj Shimin
RU2648997C2
LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A (KDM1A) INHIBITORS FOR DISEASE THERAPY 2019
  • Tapper, Emi, E..
  • Kelatka, Kassandra
  • Kler, Majkl
  • Renkhoff, Dzhr, Khyu, Yu.
RU2813145C2
COMPOUNDS OF PYRIDAZINAMIDE AND THEIR USE AS SYNTHETIC SYNECKINASIS INHIBITORS (SYK) 2013
  • Germann Jokhannes Kornelius
  • Kennedi-Smit Dzhoshua
  • Lukas Metyu S.
  • Pedilla Fernando
  • Sot Majkl
RU2627661C2
PYRAZINE DERIVATIVES USED AS ATR KINASE INHIBITORS 2009
  • Sharrer Zhan-Damen
  • Darrant Stiven
  • Kej Devid
  • Negtel Ronald
  • Makkormik Somkhearli
  • Mortimor Majkl
  • O'Donnell Majkl
  • Pinder Dzhoann
  • Rezerford Elister
  • Virani Anisa Nizarali
  • Jang Stefen
  • Riper Filip Majkl
RU2604066C2
COMPOUNDS AND METHODS FOR ENHANCED DEGRADATION OF TARGET PROTEINS AND OTHER POLYPEPTIDES BY AN E3 UBIQUITIN LIGASE 2013
  • Kruz Krejg M.
  • Bakli Dennis
  • Chulli Alessio
  • Jergensen Uillyam
  • Geriss Piter S.
  • Van Molle Inge
  • Gustafson Dzheffri
  • Tkhe Khen-Sop
  • Mishel Zhyulen
  • Khojer Dentin Uejd
  • Rot Anke G.
  • Kharling Dzhon Devid
  • Smit Yan Edvard Devid
  • Miakh Afdzhal Khussejn
  • Kampo Sebastyan Andre
  • Le Zhoell
RU2666530C2

RU 2 349 586 C2

Authors

Uitten Dzheffri P.

P'Er Fabris

Rigan Kollin

Shvebe Majkl

Jannikuros Dzhordzh Petros

Dzhung Majkl

Chua Piter

Nagasava Dzhonni J.

Dates

2009-03-20Published

2005-09-16Filed